Market Place
Sourcing Support
Biora Therapeutics Undertakes Chapter 11 Sale for Growth
30 Dec 2024 //
GLOBENEWSWIRE
Biora Therapeutics Provides Q3 2024 Update & Financials
14 Nov 2024 //
GLOBENEWSWIRE
Biora Therapeutic to Report Q3 Financial Result & Corporate Update
07 Nov 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces $3M Direct Offering Priced at Market
29 Oct 2024 //
GLOBENEWSWIRE
Biora Therapeutics Updates on BioJet™ Device at PODD Meeting
28 Oct 2024 //
#N/A
Biora Therapeutics to Reveal 00-Size BioJet Device
14 Oct 2024 //
GLOBENEWSWIRE
Biora Therapeutics To Present At Peptide Therapeutics Symposium
07 Oct 2024 //
GLOBENEWSWIRE
Biora to present At college of Gastroenterology Meeting 24
30 Sep 2024 //
GLOBENEWSWIRE
Biora Therapeutics Achieves ISO 13485 Certification
09 Sep 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Positive Nasdaq Listing Decision
28 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics to Present at H.C. Wainwright Global Investment Conference
26 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics To Present At H.C. Wainwright Investment Conference
26 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Funding Agreement with Existing Investors
12 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics Reports Q2 2024 Results And Provides Corporate Update
12 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics To Report Q2 2024 Results And Corporate Update
08 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics To Attend Canaccord Genuity Growth Conference
06 Aug 2024 //
GLOBENEWSWIRE
Biora Therapeutics Presents Phase 1 Data For BT-600 At KOL Event
18 Jul 2024 //
GLOBENEWSWIRE
Biora To Host KOL Event On NaviCap Platform And BT-600 Trial Results
08 Jul 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
01 Jul 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Presentation on the BioJet™ Systemic ODP
11 Jun 2024 //
GLOBENEWSWIRE
Biora Presents NaviCap Device Function Data At DDW 2024
20 May 2024 //
GLOBENEWSWIRE
Biora Provides Update, Reports Q1 2024 Financial Results
15 May 2024 //
GLOBENEWSWIRE
Biora To Report Q1 2024 Financials And Corporate Update
07 May 2024 //
GLOBENEWSWIRE
Biora To Present NaviCap™ Oral Delivery Data At DDW 2024
06 May 2024 //
GLOBENEWSWIRE
Biora Completes MAD Cohorts for BT-600 Clinical Trial
30 Apr 2024 //
GLOBENEWSWIRE
Biora Announces New Patent Covering its BioJet„ Liquid Jet Delivery Technology
08 Apr 2024 //
GLOBENEWSWIRE
Biora Achieves Positive Interim Results for Clinical Trial of BT-600
04 Apr 2024 //
GLOBENEWSWIRE
Biora Announces Closing of $6 Million Registered Direct Offering
03 Apr 2024 //
GLOBENEWSWIRE
Biora Announces $6 Million Registered Direct Offering
01 Apr 2024 //
GLOBENEWSWIRE
Biora Provides Corporate Update and Reports Q4 and FY23 Financial Results
26 Mar 2024 //
GLOBENEWSWIRE
Biora to Report Fourth Quarter and Full Year 2023 Financial Results
18 Mar 2024 //
GLOBENEWSWIRE
Biora Therapeutics Further Reduces Net Debt and Monetizes Legacy Asset
11 Mar 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Successful Completion of Phase 1 Study of BT-600
26 Feb 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Participation in Canaccord Bowel Disease Symposium
08 Feb 2024 //
GLOBENEWSWIRE
Biora Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
22 Jan 2024 //
GLOBENEWSWIRE
Biora Therapeutics Provides Outlook for 2024
16 Jan 2024 //
GLOBENEWSWIRE
Biora Therapeutics Announces Initiation of Phase 1 Clinical Study of BT-600
08 Jan 2024 //
GLOBENEWSWIRE
Biora Progresses Research Collaboration for BioJet Systemic Delivery Platform
02 Jan 2024 //
GLOBENEWSWIRE
Biora Announces New Patent for its NaviCap„¢ Targeted Oral Delivery Platform
19 Dec 2023 //
GLOBENEWSWIRE
Biora Accelerates Debt Reduction and Raises Capital with Institutional Investors
18 Dec 2023 //
GLOBENEWSWIRE
Biora Announces New Research Collaboration for the BioJet Delivery Platform
11 Dec 2023 //
GLOBENEWSWIRE
Biora Therapeutics Announces FDA Clearance of IND Application for BT-600
30 Nov 2023 //
GLOBENEWSWIRE
Biora Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Biora Therapeutics to Report Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
Biora Therapeutics to Submit Updated IND Application for BT-600
23 Oct 2023 //
GLOBENEWSWIRE
Biora Therapeutics Presents Data on the BioJet Systemic Oral Delivery Platform
05 Oct 2023 //
GLOBENEWSWIRE
Biora Announces Submission of IND Application to the U.S. FDA for BT-600 Program
25 Sep 2023 //
GLOBENEWSWIRE
Biora Therapeutics Reduces Debt & Largest Shareholder Increases Equity Exposure
19 Sep 2023 //
GLOBENEWSWIRE
Biora to Present at H.C. Wainwright 25th Annual Global Investment Conference
11 Sep 2023 //
GLOBENEWSWIRE
Biora Therapeutics Progresses its BioJet„¢ Systemic Oral Delivery Platform
05 Sep 2023 //
GLOBENEWSWIRE
Biora Therapeutics Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Biora Announces New Patents Covering its BioJet Systemic Oral Delivery Platform
03 Aug 2023 //
GLOBENEWSWIRE
Biora to Participate in Canaccord Genuity 43rd Annual Growth Conference
02 Aug 2023 //
GLOBENEWSWIRE
Biora Announces Study Results for NaviCap Targeted Oral Delivery Platform
27 Jul 2023 //
GLOBENEWSWIRE
Biora to Report Second Quarter 2023 Financial Results
17 Jul 2023 //
GLOBENEWSWIRE
Biora Therapeutics Continues to Monetize Legacy Diagnostics Assets
05 Jul 2023 //
GLOBENEWSWIRE
Biora Therapeutics Announces New Patents for its NaviCap
28 Jun 2023 //
GLOBENEWSWIRE
Biora Therapeutics Presents Data on the BioJet systemic Oral Delivery Platform
26 Jun 2023 //
GLOBENEWSWIRE
Biora Announces Closing of $8M Registered Direct Offering of Common Stock
14 Jun 2023 //
GLOBENEWSWIRE
Biora Announces Closing of $8 Million Registered Direct Offering of Common Stock
14 Jun 2023 //
GLOBENEWSWIRE
